Gene Expression Profiles and Prognostic Markers for Primary Breast Cancer
- 1 January 2007
- book chapter
- Published by Springer Nature
- Vol. 377, 131-138
- https://doi.org/10.1007/978-1-59745-390-5_7
Abstract
Genome-wide measures of gene expression have been used to classify breast tumors into clinically relevant subtypes, as well as provide a better means of risk assessment on an individual basis for lymph node-negative (LNN) breast cancer patients. We have applied Affymetrix GeneChips of 22,000 transcripts to analyze total RNA of frozen tumor samples from 286 LNN breast cancer patients in order to identify a gene signature for identification of patients at high risk for distant recurrence.Keywords
This publication has 19 references indexed in Scilit:
- Gene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon CancerJournal of Clinical Oncology, 2004
- Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessmentThe Lancet, 2003
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Gene expression predictors of breast cancer outcomesThe Lancet, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Identification of high risk breast-cancer patients by gene expression profilingThe Lancet, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Molecular portraits of human breast tumoursNature, 2000